Form 4: SANUWAVE Health Executive Acquires Stock Options in Lieu of Bonus

Nanci Gilmore, Chief Commercial Officer of SANUWAVE Health, Inc., acquired 1,571 stock options on January 31, 2025, in lieu of a portion of her 2024 annual cash bonus.

Summary

• Nanci Gilmore, the Chief Commercial Officer of SANUWAVE Health, Inc., filed a Form 4 on February 7, 2025, reporting a transaction.
• On January 31, 2025, Gilmore acquired 1,571 stock options with an exercise price of $27.70.
• These options are fully vested and expire on January 31, 2030.
• The options were granted in lieu of a portion of her 2024 annual cash bonus.
• Gilmore also disposed of 1,571 stock options with an exercise price of $15.67.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a routine disclosure of executive compensation. The acquisition of options in lieu of cash could be seen as slightly positive, indicating a focus on long-term value.

Positives

• The acquisition of stock options by a key executive can be seen as a positive sign, indicating confidence in the company's future performance.
• The options being granted in lieu of a cash bonus suggests a focus on long-term value creation.

Industry Context

Executive compensation packages often include stock options to align management's interests with those of shareholders. This Form 4 filing provides transparency into the compensation structure of a key executive at SANUWAVE Health.

Stakeholder Impact

• Shareholders may view the stock option grant as a positive sign, aligning management's interests with theirs.
• Employees may see this as a standard part of executive compensation.

Key Dates

Keywords

SANUWAVE Health, Stock Options, Form 4, Executive Compensation, Nanci Gilmore, SNWV, Chief Commercial Officer